When it comes to high drug costs for consumers, pharmacy benefit managers are not the villains, the new CVS chief executive said Wednesday. When it comes to high drug costs for consumers ...

CVS Health CEO David Joyner sees a way to create a more efficient healthcare professional network under the CVS umbrella. For the second day in a row, CVS Health's (NYSE: CVS) stock price saw a ...

CVS Health Corp. shares climbed the most in more than 25 years after its fourth-quarter results signaled improved performance from the company whose insurance and drugstore units have been ...

CVS Health reported $4.6 billion in 2024 profits including $1.6 billion in the fourth quarter as the company worked to overcome rising medical expenses from patients in its health insurance ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

CVS Health CEO David Joyner defended controversial ... and instead accused manufacturers of "monopolistic" practices that keep drug costs high in the U.S. Joyner, who stepped into the role ...

CVS owns Caremark, one of the nation's three largest PBMs that collectively administer roughly 80% of prescriptions in the U.S. Those middlemen negotiate rebates with drug manufacturers on behalf ...